The AMD Experts
We’re on a mission to eliminate blindness caused by age-related macular degeneration (AMD). Our vision is bold but well within reach.
MacuLogix® is a company that equips eye care professionals with the technology, tools, and education needed to help identify and manage AMD patients early, before irreversible vision loss has occurred. We can help you deliver better patient care with the scientifically validated AdaptDx Pro®.
Help us save the eyesight of millions by making early functional testing for AMD a routine part of eye care for your aging patients.
Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.
By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize that what’s good for our patients winds up being good for our practices.
Latest News & Upcoming EventsView More
In a special Good Day PA segment, an interviewer connected with Dr. Gary Kirman on the importance of optimal care when it comes to eye health, particularly with regard to AMD.
Testing dark adaptation speed for every patient over 50 allows eye care professionals prioritize both patients and practice. By Tammy Tully, OD.
Victoria Dzurinko, OD, MBA, FAAO, discusses the opportunity available to improve both patient outcomes and practice bottom lines by integrating dark adaptation testing in the identification and management of AMD.
Put Our Expertise to Work
Testing with AdaptDx Pro
AdaptDx Pro identifies impaired dark adaptation—the earliest warning sign of AMD.
Each AdaptDx Pro purchase is supported by our AMD Excellence Program® to help you achieve your patient care and practice revenue goals.